Company Filing History:
Years Active: 2006
Title: The Innovations of Stephen Ayers
Introduction
Stephen Ayers is an accomplished inventor based in Logan Township, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of prostaglandin E2 synthase inhibitors. His work is characterized by a focus on developing methods that enhance the understanding of drug potency and toxicity.
Latest Patents
Stephen Ayers holds a patent titled "Methods for determining the potency, specificity, and toxicity of microsomal prostaglandin E2 synthase." This patent provides innovative methods for assessing the potency, specificity, and toxicity of inhibitors related to microsomal prostaglandin E2 synthase. The techniques outlined in this patent utilize a cell-based assay system, which represents a significant advancement in pharmaceutical research.
Career Highlights
Ayers is currently employed at Aventis Pharmaceuticals Inc., where he continues to contribute to the development of new therapeutic solutions. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Throughout his career, Stephen has collaborated with notable colleagues, including Yang Cao and Jeffrey Stephen Sabol. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen Ayers exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of drug potency and toxicity assessment, highlight the importance of research and development in creating effective therapeutic solutions.